Drug industry on verge of rare defeat

Democrats claim they have the support needed in Congress to approve legislation aimed at reducing exorbitant medication prices, putting the powerful pharmaceutical industry at risk of a rare loss.

The legislation would allow negotiations for up to 10 of the highest cost drugs beginning in 2026,

Half of all medications covered by Medicare had price increases between 2019 and 2020 that were higher than the rate of inflation, according to the Kaiser Family Foundation.

Mitchell said if the legislation passes, it would pierce the pharmaceutical lobby’s veneer of invincibility.

drug companies have fought to keep their power to dictate prices,” Mitchell said